62 related articles for article (PubMed ID: 6260511)
21. Activation of complement by Schistosoma mansoni schistosomula: killing of parasites by the alternative pathway and requirement of IgG for classical pathway activation.
Santoro F; Lachmann PJ; Capron A; Capron M
J Immunol; 1979 Oct; 123(4):1551-7. PubMed ID: 113459
[TBL] [Abstract][Full Text] [Related]
22. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
Kozlov LV; Shibanova ED; Zinchenko AA
Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
[TBL] [Abstract][Full Text] [Related]
23. Activation of the alternative complement pathway in normal human serum by Loa loa and Brugia malayi infective stage larvae.
Yates JA; Higashi GI; Lowichik A; Orihel TC; Lowrie RC; Eberhard ML
Acta Trop; 1985 Jun; 42(2):157-63. PubMed ID: 2862778
[TBL] [Abstract][Full Text] [Related]
24. Ehrlich ascites cells activate the alternative pathway of the human complement system.
Betz M; Hänsch GM; Shin ML
Immunobiology; 1984 May; 166(4-5):397-402. PubMed ID: 6237046
[TBL] [Abstract][Full Text] [Related]
25. [Determination of the alternative complement pathway in patients with amebic liver abscess].
Capin MR; Jiménez M; Zamacona G; Ortíz-Ortíz L
Arch Invest Med (Mex); 1978; 9 Suppl 1():297-302. PubMed ID: 697476
[TBL] [Abstract][Full Text] [Related]
26. Activation of the alternative pathway of complement by Entamoeba histolytica.
Ortiz-Ortiz L; Capin R; Capin NR; Sepúlveda B; Zamacona G
Clin Exp Immunol; 1978 Oct; 34(1):10-8. PubMed ID: 219975
[TBL] [Abstract][Full Text] [Related]
27. Analysis of complement-dependent antibody-mediated lysis of target cells acutely infected with measles.
Hicks JT; Klutch MJ; Albrecht P; Frank MM
J Immunol; 1976 Jul; 117(1):208-15. PubMed ID: 819582
[TBL] [Abstract][Full Text] [Related]
28. The expression and localization of surface neoantigens in transformed and untransformed cultured cells infected with avian tumor viruses.
Phillips ER; Perdue JF
J Supramol Struct; 1976; 4(1):27-44. PubMed ID: 1256061
[TBL] [Abstract][Full Text] [Related]
29. Alternative complement pathway-mediated myeloid cell cytotoxicity: repertoire of membrane factors participating in regulation of C3 deposition and cytolysis.
Matsumoto M; Sugita Y; Seya T
Eur J Immunol; 1991 Aug; 21(8):1787-92. PubMed ID: 1714391
[TBL] [Abstract][Full Text] [Related]
30. Alternative pathway for complement activation triggered by human liver plasma membranes.
Corrocher R; Falezza GC; Casaril M; Aprili G; De Sandre G
Hepatogastroenterology; 1981 Aug; 28(4):195-8. PubMed ID: 7024075
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
[TBL] [Abstract][Full Text] [Related]
32. A factor activating complement via the alternative pathway in the supernatants of B cell lines transformed by Epstein-Barr virus and in sera obtained from patients with systemic lupus erythematosus.
Hiramatsu M; Tsokos GC
Int Arch Allergy Appl Immunol; 1988; 86(2):209-14. PubMed ID: 2839425
[TBL] [Abstract][Full Text] [Related]
33. Activation of homologous complement via the alternative complement pathway by quail cells transformed by Rous sarcoma virus.
Kai C; Yoshikawa Y; Okada H; Yamanouchi K
J Vet Med Sci; 1995 Oct; 57(5):911-5. PubMed ID: 8593301
[TBL] [Abstract][Full Text] [Related]
34. Cytolysis of Sendai virus-infected guinea-pig cells by homologous complement.
Okada H; Tanaka H; Okada N
Immunology; 1983 May; 49(1):29-35. PubMed ID: 6301976
[TBL] [Abstract][Full Text] [Related]
35. Activation of the alternative complement pathway by mumps infected cells: relationship to viral neuraminidase activity.
Hirsch RL; Wolinsky JS; Winkelstein JA
Arch Virol; 1986; 87(3-4):181-90. PubMed ID: 3947239
[TBL] [Abstract][Full Text] [Related]
36. Tumor cells treated with vaccinia virus can activate the alternative pathway of mouse complement.
Wakamiya N; Okada N; Wang YL; Ito T; Ueda S; Kato S; Okada H
Jpn J Cancer Res; 1989 Aug; 80(8):765-70. PubMed ID: 2511185
[TBL] [Abstract][Full Text] [Related]
37. The interaction of cells persistently infected with canine distemper virus with antiviral antibody and complement.
Gorman NT
Cell Immunol; 1983 Apr; 77(2):242-8. PubMed ID: 6850842
[TBL] [Abstract][Full Text] [Related]
38. Activation of chicken alternative complement pathway by fowlpox virus-infected cells.
Ohta H; Kai C; Yoshikawa Y; Yamanouchi K
Infect Immun; 1983 Nov; 42(2):721-7. PubMed ID: 6315584
[TBL] [Abstract][Full Text] [Related]
39. A study of the sensitivity of erythrocytes to lysis by heterologous sera via the alternative complement pathway.
Van Dijk H; Heezius E; Van Kooten PJ; Rademaker PM; Van Dam R; Willers JM
Vet Immunol Immunopathol; 1983 May; 4(4):469-77. PubMed ID: 6868341
[TBL] [Abstract][Full Text] [Related]
40. Nonspecific activation of complement by leukemic cells.
Shimbo T; Yata J; Okada H
Int J Cancer; 1978 Oct; 22(4):422-5. PubMed ID: 700897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
